🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The Personalized Discovery Process is the only program offering patients tr...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-01
Trial ID
NCT02363647
Treatments Being Tested
Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Status
Recruiting
Location
Cleveland Clinic Main Campus
Start Date
2025-12-17
Trial ID
NCT07058155
This is a feasibility study evaluating the use of a mathematical model to p...
Status
Completed
Location
University of New Mexico Comprehensive Cancer Center
Start Date
2015-06-02
Trial ID
NCT03983538
Treatments Being Tested
This pragmatic randomized controlled trial evaluates whether Qiling Yiqi Ta...
Status
Not Yet Recruiting
Location
Beijing University of Traditional Chinese Medicine
Start Date
2026-08
Trial ID
NCT07698574
Treatments Being Tested
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
The aim of the study is to assess the continued efficacy and safety of coch...
Status
Recruiting
Location
Stanford University
Start Date
2022-08-19
Trial ID
NCT05318417
Treatments Being Tested
To explore the efficacy and safety of vebreltinib plus platinum-doublet che...
Status
Not Yet Recruiting
Location
241 West Huaihai Road, Xuhui District, Shanghai, 200030, China.
Start Date
2026-03-30
Trial ID
NCT07549061
Treatments Being Tested
Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2024-02-13
Trial ID
NCT06313203
Treatments Being Tested
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested